Zinc-Based Nanoparticles Reduce Bacterial Biofilm Formation.
Rafael Bianchini FulindiJuliana Domingues RodriguesThulio Wliandon Lemos BarbosaAriana D Goncalves GarciaFelipe de Almeida La PortaSebastião PratavieiraLeila Aparecida ChiavacciJoão Pessoa Araújo JuniorPaulo Inacio CostaLuis R MartinezPublished in: Microbiology spectrum (2023)
Biofilm formation is important for microbial survival in hostile environments and a phenotype that provides microorganisms with antimicrobial resistance. Zinc oxide (ZnO) and Zinc sulfide (ZnS) nanoparticles (NPs) present potential antimicrobial properties for biomedical and food industry applications. Here, we aimed to analyze, for the first time, the bactericidal and antibiofilm activity of ZnS NPs against Staphylococcus aureus, Klebsiella oxytoca, and Pseudomonas aeruginosa, all medically important bacteria in developed countries. We compared ZnS NPs antimicrobial activity to ZnO NPs, which have been extensively studied. Using the colorimetric XTT reduction assay to observe the metabolic activity of bacterial cells and the crystal violet assay to measure biofilm mass, we demonstrated that ZnS and ZnO had similar efficacy in killing planktonic bacterial cells and reducing biofilm formation, with S. aureus being more susceptible to both therapeutics than K. oxytoca and P. aeruginosa. Crystal violet staining and confocal microscopy validated that Zn NPs inhibit biofilm formation and cause architectural damage. Our findings provide proof of principle that ZnS NPs have antibiofilm activity, and can be potentially used in medical and food industry applications, such as treatment of wound infections or package coating for food preservation. IMPORTANCE Zinc (Zn)-based nanoparticles (NPs) can be potentially used in medical and food preservation applications. As proof of principle, we investigated the bactericidal and antibiofilm activity of zinc oxide (ZnO) and zinc sulfide (ZnS) NPs against medically important bacteria. Zn-based NPs were similarly effective in killing planktonic and biofilm-associated Staphylococcus aureus, Klebsiella oxytoca, and Pseudomonas aeruginosa cells. However, S. aureus was more susceptible to these investigational therapeutics. Although further studies are warranted, our findings suggest the possibility of future use of Zn-based NPs in the treatment of skin infections or preservation of food.
Keyphrases
- biofilm formation
- oxide nanoparticles
- pseudomonas aeruginosa
- staphylococcus aureus
- quantum dots
- candida albicans
- induced apoptosis
- escherichia coli
- cystic fibrosis
- sensitive detection
- cell cycle arrest
- antimicrobial resistance
- acinetobacter baumannii
- oxidative stress
- heavy metals
- healthcare
- methicillin resistant staphylococcus aureus
- climate change
- randomized controlled trial
- clinical trial
- signaling pathway
- high throughput
- multidrug resistant
- hydrogen peroxide
- reduced graphene oxide
- room temperature
- mass spectrometry
- single molecule
- microbial community
- combination therapy
- wound healing
- fluorescent probe
- soft tissue